Molecular Tumor Board Improves Outcomes for Hispanic Patients With Advanced Solid Tumors
JCO Global Oncology · 2024
DOI: 10.1200/go.23.00011 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Global Oncology, 2024. Verfasst von Carolina Sotelo-Rodríguez und 18 weiteren Autor:innen. Beteiligte Einrichtung: Foundation for Clinical and Applied Cancer Research-FICMAC, Bogotá, Colombia. Hauptthemen laut MEDLINE: Hispanic or Latino, Neoplasms, Outcome Assessment, Health Care. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
PURPOSE Multidisciplinary molecular tumor boards (MTBs) decode complex genomic data into clinical recommendations. Although MTBs are well-established in the oncology practice in developed countries, this strategy needs to be better explored in developing countries. Herein, we describe the possible benefits and limitations of the first MTB established in Colombia. METHODS Demographic, clinical, and genomic information was collected between August 2020 and November 2021. By mid-2020, an MTB strategy was created to discuss clinical cases with one or more genomic alterations identified by next-generation sequencing using an open-access virtual platform. We characterized the patient population as benefiting from the recommended treatment option. We assessed the benefits and access to available targeted therapies that have the potential to change clinical management by making recommendations to treating oncologists on the basis of genomic profiling. However, we did not assess the treatment oncologists' compliance with MTB recommendations because they were not intended to replace clinical judgment/standard of care. RESULTS A total of 146 patients were included in the discussions of the MTB. The median age was 59 years, and 59.6% were women. Genomic results prompting a change in therapeutic decisions were obtained in 53.1% of patients (95% CI, 44.9 to 61.3). The most prevalent malignancy was non–small-cell lung cancer (51%). Other malignancies represented 60%, 50%, and 30% of patients with soft-tissue sarcomas, brain tumors, and breast cancer, respectively. CONCLUSION Using an open-access virtual platform, MTBs were feasible in low- and middle-income countries on the basis of the capability to provide the benefits and access to available targeted therapies that are not standard of care. Furthermore, MTB recommendations were made available to the treating oncologist in different locations across Colombia, providing the option to modify clinical management in most of these patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Foundation for Clinical and Applied Cancer Research-FICMAC, Bogotá, Colombia.
- Molecular Oncology and Biology Systems Research Group (Fox-G), Universidad El Bosque, Bogotá, Colombia.
- Thoracic Oncology Unit, Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center (CTIC), Bogotá, Colombia.
- Hematology/Oncology Division, Mayo Clinic, Scottsdale, AZ.
- Thoracic Oncology Unit, Clínica Las Américas, Medellín, Colombia.
- Thoracic Oncology Unit, National Cancer Institute (INCan), México City, México.
ORCID-Profile: Carolina Sotelo-Rodríguez, Dora Vallejo-Ardila, Alejandro Ruiz-Patiño, Hernán Carranza, Leonardo Rojas, Cladelis Rubio, Camila Ordóñez-Reyes, Juan Esteban Garcia-Robledo, Sergio Mejía, Elvira Jaller, Oscar Arrieta
Zitieren
APA
Sotelo-Rodríguez, C., Vallejo-Ardila, D., Ruiz-Patiño, A., Chamorro, D. F., Rodríguez, J., Moreno-Pérez, D. A., Carranza, H., Otero, J., Vargas, C., Archila, P., Rojas, L., Zuluaga, J., Rubio, C., Ordóñez-Reyes, C., Garcia-Robledo, J. E., Mejía, S., Jaller, E., Arrieta, O., & Cardona, A. F. (2024). Molecular Tumor Board Improves Outcomes for Hispanic Patients With Advanced Solid Tumors. JCO Global Oncology. https://doi.org/10.1200/go.23.00011
Vancouver
Sotelo-Rodríguez C, Vallejo-Ardila D, Ruiz-Patiño A, Chamorro DF, Rodríguez J, Moreno-Pérez DA, et al. Molecular Tumor Board Improves Outcomes for Hispanic Patients With Advanced Solid Tumors. JCO Global Oncology. 2024. doi:10.1200/go.23.00011
BibTeX
@article{SoteloRodrguez2024,
author = {Sotelo-Rodríguez, Carolina and Vallejo-Ardila, Dora and Ruiz-Patiño, Alejandro and Chamorro, Diego F and Rodríguez, July and Moreno-Pérez, Darwin A and Carranza, Hernán and Otero, Jorge and Vargas, Carlos and Archila, Pilar and Rojas, Leonardo and Zuluaga, Jairo and Rubio, Cladelis and Ordóñez-Reyes, Camila and Garcia-Robledo, Juan Esteban and Mejía, Sergio and Jaller, Elvira and Arrieta, Oscar and Cardona, Andrés F},
title = {Molecular Tumor Board Improves Outcomes for Hispanic Patients With Advanced Solid Tumors},
journal = {JCO Global Oncology},
year = {2024},
doi = {10.1200/go.23.00011}
}
EUVIMED